FRANCE - Secrétariat général des Affaires européennes
Public authority · France
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts — staff, costs, accreditations — are not available for it.
4
positions filed
in the 583 files tracked
4
legislative files
of 583 tracked
0
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Work at FRANCE - Secrétariat général des Affaires européennes? so we know who speaks for it.
Their record over time
FRANCE - Secrétariat général des Affaires européennes filed 4 positions between 13 Dec 2020 and 27 Apr 2021, across 4 of the 583 legislative files tracked here.
FR supported the general objectives and the different options for the evolution of the scheme. The revision of the EU texts will make it possible to adapt and speed up MA procedures in line with scientific and technical developments.
Filed in French · English published by the European Commission
The French authorities (FAs) welcome significant and structured progress made since the publication of the European Strategy for Data in February 2020, including the proposed legislative roadmap and available financial instruments such as the TEHDaS Joint Action, which have allowed to create a catalyst moment around the creation of a future European Health Data Space (EHDS).
France is not in favour of option 1 as it would not reinforce cross-country harmonisation of quality & safety standards nor protection of donors nor benefit patients relying on BTC therapies. FR supports option 2, which allows the consultation & implication of representatives from BTC establishments & experts from all over EU.
The French authorities (FAs) welcome the significant advances that Regulations (EC) No. 141/2000 (orphan medicinal products for rare deseases) and (EC) No. 1901/2006 (medicinal products for paediatric use) have made possible since their entry into force.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put FRANCE - Secrétariat général des Affaires européennes next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Everything on this page comes from FRANCE - Secrétariat général des Affaires européennes’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.